Loan licence manufacture under central excise treated the licence holder as manufacturer, defeating buyer-price valuation and penalties.

Where medicaments are manufactured at another premises under a loan licence arrangement, the decisive question is who exercised control over production and held out as the manufacturer. On the facts, the loan licence holders were treated as the manufacturers for central excise purposes, not the job workers. Valuation therefore had to follow the excise valuation framework applicable to those clearances, and the buyer's selling price was not the correct basis. The extended-period demand was also held unsustainable on the factual matrix, so the penalties could not survive. The appeals were allowed and the duty demand and penalties were set aside.

---

---

Issues: (i) Whether the loan licence holders or the job workers were the manufacturers for central excise purposes in the circumstances of production of medicaments at another factory; (ii) whether the assessable value was to be determined on the basis of the buyer's selling price or on the basis of the principles applicable to job-work manufacture; (iii) whether the demand could be sustained for the extended period and penalties could be imposed.

Issue (i): Whether the loan licence holders or the job workers were the manufacturers for central excise purposes in the circumstances of production of medicaments at another factory.

Analysis: The decisive test was whether the production was carried out under the control and supervision of the loan licence holders. The majority found that the arrangement, the agreement terms, the supply of raw materials and packing materials, and the manner in which the goods were manufactured and accounted for showed that the loan licence holders were the independent manufacturers and that the job workers were not the manufacturers in their own right. The contrary view in dissent treated the job workers as the actual manufacturers on the facts and agreement terms.

Conclusion: The loan licence holders were held to be the manufacturers for excise purposes.

Issue (ii): Whether the assessable value was to be determined on the basis of the buyer's selling price or on the basis of the principles applicable to job-work manufacture.

Analysis: The majority held that once the loan licence holders were treated as manufacturers, valuation had to follow the Central Excise valuation scheme applicable to such clearances and not the selling price of the goods in the hands of the loan licence holders. The valuation principles of Ujjagar Prints and allied job-work cases were held not to govern the present facts in the majority view, whereas the dissent considered the matter to fall within the job-work line of authority and required valuation after allowing the admissible deductions.

Conclusion: The demand based on the buyer's selling price was not sustainable and the appeals succeeded on valuation.

Issue (iii): Whether the demand could be sustained for the extended period and penalties could be imposed.

Analysis: The majority accepted the plea against the extended period and held that the factual matrix did not justify the demand being sustained on that basis. Consequentially, the penalties also could not survive. The dissent, while not agreeing with the full allowance, did not alter the majority outcome once the reference was answered in favour of the appellants.

Conclusion: The extended-period demand and penalties were set aside.

Final Conclusion: The appeals were allowed in the majority, the impugned order was set aside, and the appellants obtained relief from the duty demands and penalties.

Ratio Decidendi: Where medicaments are manufactured at another premises under a loan licence arrangement and the facts show that the licence holder exercises the relevant control and holds itself out as the manufacturer, that holder is treated as the manufacturer for central excise purposes and valuation must be made under the applicable excise valuation rules on the facts proved.

---